Contents


Foreword Kevin G Kerr


Consultant Microbiologist and Director of Infection Prevention and Control, Harrogate and District NHS Foundation Trust


Editorial


Multi-azole Resistance in Aspergillus – Only a Northern European Problem? David W Denning


Professor of Medicine and Medical Mycology, The National Aspergillosis Centre, School of Translational Medicine, The University of Manchester


HIV and AIDS


Antiretroviral Options for Naïve and Virologically Controlled Patients Nadia Valin,1


Jérôme Pacanowski1 and Pierre-Marie Girard1,2


1. Department of Infectious Diseases and Tropical Medicine, Hopital St Antoine, Assistance Publique-Hôpitaux de Paris and Faculté de Médecine Pierre et Marie Curie, Paris; 2. INSERM Unit 707, 75012 Paris


Soft Tissue Volume Fillers in the Treatment of HIV-associated Facial Lipoatrophy


Giovanni Guaraldi


Assistant Professor, Integrated Department of Medicine and Medical Specialities, University of Modena and Reggio Emilia


Fungal Infections


Cryptococcal Meningitis – Global Public Health Challenges and Opportunities


Eszter Deak and Benjamin J Park


Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, US Centers for Disease Control and Prevention


Overview of Albaconazole Javier Bartroli1


88 and Manuel Merlos2 1. Chief Technology Officer; 2. Chief Scientific Officer, Palau Pharma S.A., Barcelona Bacterial Infections


Antimicrobial Resistance Lindsay E Nicolle


Professor, Department of Internal Medicine and Medical Microbiology, University of Manitoba, Health Sciences Centre, Winnipeg


Overview of Oritavancin Stephan Billstein1


98 and Gina Eagle2


1. Medical Director; 2. Senior Medical Director, The Medicines Company, Parsippany


A Brief Overview of Mycobacterial Diseases in Children Charles C Obihara,1,4


Ben J Marais,2 Anne K Detjen3 102 and Marceline A Van Furth4


1. Department of Paediatrics, St Elisabeth Hospital, Tilburg; 2. Children’s Hospital at Westmead and Sydney Emerging Infectious Diseases and Biosecurity Institute, Sydney Medical School, University of Sydney; 3. International Union Against Tuberculosis and Lung Disease, New York; 4. Department of Pediatric Infectious Diseases, Immunology and Rheumatology, VU University Medical Centre, Amsterdam


92 83 80 73 71 69


EUROPEAN INFECTIOUS DISEASE


65


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92